bezafibrate has been researched along with efaproxiral in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, DJ; Mahran, MA; Mehanna, AS; Randad, RS | 1 |
| Aiello, F; Caroleo, MC; Carullo, G; Cione, E; Governa, P; Manetti, F | 1 |
| Caroleo, MC; Cione, E; Kagechika, H; Manetti, F | 1 |
1 review(s) available for bezafibrate and efaproxiral
| Article | Year |
|---|---|
FFAR1/GPR40: One target, different binding sites, many agonists, no drugs, but a continuous and unprofitable tug-of-war between ligand lipophilicity, activity, and toxicity.
Topics: Binding Sites; Drug Development; Humans; Hypoglycemic Agents; Ligands; Receptors, G-Protein-Coupled | 2021 |
2 other study(ies) available for bezafibrate and efaproxiral
| Article | Year |
|---|---|
Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
Topics: Allosteric Regulation; Aniline Compounds; Antisickling Agents; Chemical Phenomena; Chemistry; Hemoglobin A; Humans; Oxygen; Propionates; Structure-Activity Relationship | 1991 |
Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release.
Topics: Allosteric Regulation; Aniline Compounds; Animals; Bezafibrate; Cells, Cultured; Dose-Response Relationship, Drug; Drug Repositioning; Fibric Acids; Humans; Insulin; Ligands; Molecular Docking Simulation; Molecular Structure; Propionates; Rats; Receptors, G-Protein-Coupled; Retinoids; Structure-Activity Relationship | 2021 |